Spots Global Cancer Trial Database for Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
Official Title: Determination and Validation of Lung EpiCheck®: A Multianalyte Assay for Lung Cancer Prediction. A Case-Control Study
Study ID: NCT04968548
Conditions
Interventions
Study Description
Brief Summary: This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
Detailed Description: This is a prospective, case-control, multi-center, observational nonsignificant risk study. The study aims to collect blood and clinical data from subjects undergoing Low Dose CT (LDCT) for lung cancer screening and subjects with confirmed lung cancer.
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Scripps Memorial Hospital, Encinitas, California, United States
Centura Health, Lakewood, Colorado, United States
VA Connecticut Healthcare System, West Haven, Connecticut, United States
Orlando Health, Inc., Orlando, Florida, United States
Sarasota Memorial Hospital, Sarasota, Florida, United States
St. Elizabeth Edgewood Hospital, Edgewood, Kentucky, United States
Norton Cancer Institute, Louisville, Kentucky, United States
Owensboro Health, Owensboro, Kentucky, United States
Johns Hopkins Medical Center, Baltimore, Maryland, United States
Lahey Hospital and Medical Center, Burlington, Massachusetts, United States
University of Minnesota Health, Minneapolis, Minnesota, United States
Harry S. Truman Memorial Veterans' Hospital, Columbia, Missouri, United States
Washington University in St. Louis, Saint Louis, Missouri, United States
Northwell Health, New Hyde Park, New York, United States
University of Rochester, Rochester, New York, United States
The University of North Carolina, Chapel Hill, North Carolina, United States
Duke University, Durham, North Carolina, United States
Durham VA Health Care System, Durham, North Carolina, United States
W.G. (Bill) Hefner VA Medical Center, Salisbury, North Carolina, United States
Novant Health Cancer Research, Winston-Salem, North Carolina, United States
Summa Health, Akron, Ohio, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States
Medical University of South Carolina (MUSC), Charleston, South Carolina, United States
Baptist Cancer Center, Memphis, Tennessee, United States
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
University of Calgary, Calgary, Alberta, Canada
Vancouver General Hospital/The University of British Columbia, Vancouver, British Columbia, Canada
University Health Network, Toronto, Ontario, Canada
McGill University Health Centre, Montréal, Quebec, Canada
Contact Details
Name: Radha Duttagupta, PhD
Affiliation: Nucleix Ltd.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
